Our 2'-O-Methyl RNA Bases service supports research teams that need precise DNA/RNA modification for antisense oligonucleotides, siRNA, guide RNA, probes, and custom chimeric oligos. 2'-O-methyl RNA bases replace the ribose 2'-hydroxyl with a methoxy group, helping improve nuclease resistance and tune hybridization behavior while giving scientists a practical way to control how a modified oligonucleotide performs in real workflows.
We support end-to-end project execution from modification pattern planning and custom synthesis to purification, analytical confirmation, and delivery of research-use oligos. Whether your program requires fully modified 2'-OMe RNA, a DNA/2'-OMe RNA chimera, or a mechanism-aware design integrated into broader DNA/RNA modification workflows, we help align sequence architecture with synthesis feasibility, assay compatibility, and downstream project goals.
Mechanism Fit: 2'-OMe placement should match the intended mechanism rather than be added as a generic stability upgrade. Fully modified or heavily modified sequences are often selected for steric-blocking and stabilization strategies, while RNase H-oriented programs usually require a DNA-containing gap instead of a fully 2'-OMe backbone.
Placement Strategy: Terminal protection, alternating substitution, seed-region tuning, and full-sequence replacement can produce very different outcomes in duplex stability, specificity, and target recognition. We help define where mA, mC, mG, and mU should be introduced based on target type and experimental purpose.
Mixed-Backbone Manufacturability: DNA/2'-OMe RNA chimeras and other mixed-chemistry constructs can become difficult to synthesize, purify, and reproduce when sequence length, modification density, and auxiliary chemistries all increase together. Our team plans synthesis routes that reduce avoidable complexity before the project moves to execution.
Analytical Confidence: Modified oligos need more than a sequence printout. We provide purity planning, mass confirmation, and fit-for-purpose QC review so project teams can distinguish between a theoretically correct design and a material that is actually ready for screening or assay use.
Workflow Compatibility: 2'-OMe RNA bases are used differently in antisense, RNAi, CRISPR guide stabilization, and probe development. Our service approach is informed by the practical design logic behind antisense oligonucleotide synthesis, modified siRNA programs, and guide RNA engineering rather than relying on a one-pattern-fits-all modification scheme.
Our services are designed for customers who need custom incorporation of 2'-O-methyl RNA bases into oligonucleotides with clear technical reasoning behind every modification site. We support sequence formats ranging from short modified probes to DNA/RNA chimeras, antisense tools, RNAi duplexes, and guide RNA stabilization projects.
By combining sequence review, chemistry planning, purification strategy, and QC documentation, we help reduce redesign cycles and make 2'-OMe oligos easier to evaluate, compare, and transfer into downstream research workflows.
We Provide the Following 2'-Omethyl RNA Bases
This table helps research teams compare common 2'-OMe implementation formats for DNA/RNA modification and select a structure that better matches target biology, assay design, and manufacturing constraints.
| Modification Format | Primary Use | Typical Placement Strategy | Main Benefit | Key Design Watchpoint |
| Fully 2'-OMe RNA Oligo | Steric blocking, stabilized hybridization tools, and nuclease-tolerant research oligos | All residues replaced with mA, mC, mG, and/or mU | Strong stability profile with straightforward modification identity | Not suitable when a DNA-dependent RNase H mechanism is required |
| DNA/2'-OMe RNA Chimera | Mixed-backbone antisense, probe, and custom assay designs | DNA and 2'-OMe residues placed in defined blocks or site-specific positions | Balances modification control with flexible sequence engineering | Junction design and modification density can complicate synthesis and purification |
| 2'-OMe Wing Gapmer | Antisense programs that need a protected outer region with a DNA core | 2'-OMe residues placed on both ends of a central DNA gap | Combines improved stability with an architecture compatible with RNase H-oriented design | Gap length, wing size, and backbone choices must be tuned together |
| 2'-OMe siRNA Duplex | RNAi screening and duplex optimization | Selected residues placed on guide and/or passenger strands rather than full random substitution | Supports duplex tuning, stability improvement, and mechanism-aware refinement | Over-modification can alter strand behavior and reduce desired activity |
| 2'-OMe Guide RNA | sgRNA, crRNA, or tracrRNA stabilization in genome-editing research | Often focused at sequence ends or other predefined susceptible positions | Improves handling robustness for guide RNA workflows | Placement should be reviewed against guide architecture and edit workflow requirements |
| 2'-OMe Probe Oligo | Hybridization probes, capture oligos, and labeled detection constructs | 2'-OMe bases combined with reporter labels, biotin, or spacers | Useful for building stable and application-specific recognition tools | Label position and spacer choice can affect signal and target accessibility |
Successful 2'-OMe oligo projects depend on more than ordering a modified sequence. The review matrix below summarizes the key technical checks used to align modification strategy with synthesis feasibility, analytical confidence, and downstream use.
| Review Category | What We Assess | Why It Matters | Typical Deliverables | Stage Alignment |
| Mechanism Review | Whether the project needs steric blocking, duplex stabilization, probe binding, or a DNA-gap architecture | Prevents the use of a modification pattern that conflicts with the intended biological mechanism | Design comments, placement recommendations, and sequence revision notes | Project initiation |
| Sequence Mapping | Exact locations of mA, mC, mG, and mU within DNA, RNA, or mixed-backbone constructs | Ensures the final sequence can be interpreted, quoted, reproduced, and transferred correctly | Annotated sequence map and modification legend | Design phase |
| Synthesis Feasibility | Length, chemistry density, backbone composition, and optional label or linker burden | Identifies manufacturability issues before they become purification or yield problems | Feasibility review and production planning notes | Pre-synthesis |
| Purification Planning | Required purity level, impurity tolerance, and fit-for-purpose purification route | Avoids under-purifying sensitive constructs or over-specifying simple screening materials | Recommended purification method and release criteria | Pre-synthesis / post-synthesis |
| Analytical Confirmation | Identity, composition, and purity checks appropriate for the modified oligo format | Provides confidence that the delivered material matches the planned architecture | QC report, mass data summary, and purity information | Release stage |
| Duplex Preparation | Whether strands need to be delivered as separate components or as a prepared duplex | Reduces handling variability for siRNA and other two-strand workflows | Strand pairing plan and duplex delivery option | Post-synthesis |
| Conjugation Compatibility | Interaction of 2'-OMe residues with biotin, fluorophores, phosphate, amine, or spacer designs | Helps preserve function when additional chemical features are required for assay use | Conjugation strategy notes and sequence layout suggestions | Design / customization |
| Reorder Continuity | Batch consistency, recurring sequence demand, and documentation needs for repeat projects | Supports smoother transition from pilot ordering to lead-sequence follow-up work | Reorder-ready specifications and project history support | Follow-on production |
This workflow reflects how our team supports customers from sequence definition to final data handoff for 2'-OMe-modified DNA/RNA oligonucleotides used in research, assay development, and platform evaluation.
We confirm the target sequence, intended application, desired modification pattern, backbone preferences, scale, and purification needs. This step is used to determine whether the project is best served by a fully modified oligo, a DNA/RNA chimera, or a mechanism-specific architecture.
Our scientists map the positions of 2'-O-methyl RNA bases and review optional chemistry combinations such as phosphorothioates, end labels, or spacers. The goal is to align biological intent with a modification plan that is both technically sound and manufacturable.
Once the sequence architecture is fixed, we establish the synthesis route based on oligo length, chemistry complexity, and batch requirements. Special attention is given to mixed-backbone sequences and projects with multiple modified positions or terminal functional groups.
The crude material is purified using a method appropriate for the construct and then evaluated through fit-for-purpose analytical review. This stage is essential for confirming that the delivered oligo is suitable for screening, duplexing, probe preparation, or follow-on biological studies.
When required, we support strand pairing, additional end modifications, or preparation of assay-ready sequence formats. This helps reduce handling variability for customers working with duplex RNA, labeled probes, or modification-sensitive experimental setups.
Final materials are delivered with the agreed sequence documentation and QC package so project teams can move efficiently into validation or downstream studies. The handoff is structured to support reordering, internal review, and future sequence optimization.
Customers choose our platform when they need more than basic oligo ordering. We focus on technical clarity, modification placement logic, and practical execution so that 2'-OMe projects move forward with fewer avoidable redesigns and stronger alignment between chemistry and application.
2'-O-methyl RNA bases are widely used in custom modified oligonucleotides where stability, sequence recognition, and workflow compatibility must be tuned more precisely than standard DNA or RNA can provide. Our service supports a range of research and platform-development applications.
Whether you need a fully modified 2'-OMe oligo, a DNA/2'-O-methyl RNA chimera, a guide RNA stabilization design, or a broader custom modified oligonucleotide workflow, our team can help you move from concept to research-ready material with clear technical support. We work with biotech companies, pharmaceutical research teams, CRO groups, and academic laboratories that need precise 2'-O-methyl RNA base incorporation, practical purification strategies, and reliable documentation for downstream evaluation. If your project involves DNA/RNA modification, antisense optimization, siRNA design, probe construction, or guide RNA engineering, we can help define an efficient synthesis and QC path around your exact sequence requirements.
RNA modification involves covalent changes to RNA molecules, such as methylation, which can regulate RNA translation and stability. These modifications are critical for understanding gene expression and RNA function in various biological processes.
2'-O-methylation is a modification where a methyl group is added to the 2'position of the ribose sugar in RNA. This modification enhances RNA stability, resistance to nucleases, and improves binding affinity, especially in applications like antisense and RNA interference (RNAi).
2'-O-methylation provides nuclease resistance, making RNA molecules more stable in biological environments. This modification is particularly useful in RNA-based research, such as antisense oligonucleotides and siRNA, by preventing degradation.
2'-O-methyl RNA bases are widely used in antisense, RNAi, aptamer research, and CRISPR technology. They help enhance the stability, specificity, and efficiency of RNA-based experiments and therapeutic approaches.
2'-O-methylation improves RNA stability and binding efficiency, which is beneficial for RNA-based therapies such as gene silencing and CRISPR-based gene editing. It also increases the resistance of RNA to degradation, enhancing its therapeutic potential.
2'-O-methylation increases RNA:RNA duplex stability by raising the melting temperature (Tm), while having only minor effects on RNA:DNA hybrid stability. This makes it ideal for applications that require stable RNA duplex formation.
Loading ......
